UBS Group’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-484,121
| Closed | -$4.54M | – | 11374 |
|
|
2021
Q3 | $4.54M | Sell |
484,121
-34,932
| -7% | -$328K | ﹤0.01% | 2772 |
|
|
2021
Q2 | $4.89M | Buy |
519,053
+104
| +0% | +$978 | ﹤0.01% | 2713 |
|
|
2021
Q1 | $4.86M | Sell |
518,949
-79,875
| -13% | -$744K | ﹤0.01% | 2625 |
|
|
2020
Q4 | $5.51M | Sell |
598,824
-91,577
| -13% | -$835K | ﹤0.01% | 2350 |
|
|
2020
Q3 | $6.18M | Buy |
690,401
+11,616
| +2% | +$105K | ﹤0.01% | 2004 |
|
|
2020
Q2 | $6.06M | Sell |
678,785
-35,904
| -5% | -$317K | ﹤0.01% | 1896 |
|
|
2020
Q1 | $6.15M | Sell |
714,689
-43,459
| -6% | -$417K | ﹤0.01% | 1762 |
|
|
2019
Q4 | $7.59M | Sell |
758,148
-27,418
| -3% | -$273K | ﹤0.01% | 2203 |
|
|
2019
Q3 | $7.77M | Sell |
785,566
-13,520
| -2% | -$134K | ﹤0.01% | 1967 |
|
|
2019
Q2 | $7.92M | Buy |
799,086
+29,459
| +4% | +$290K | ﹤0.01% | 1949 |
|
|
2019
Q1 | $7.53M | Buy |
769,627
+2,350
| +0.3% | +$22.7K | ﹤0.01% | 1891 |
|
|
2018
Q4 | $6.83M | Buy |
767,277
+209,927
| +38% | +$1.97M | ﹤0.01% | 1890 |
|
|
2018
Q3 | $5.31M | Buy |
557,350
+16,244
| +3% | +$156K | ﹤0.01% | 2295 |
|
|
2018
Q2 | $5.17M | Sell |
541,106
-11,396
| -2% | -$109K | ﹤0.01% | 2315 |
|
|
2018
Q1 | $5.34M | Sell |
552,502
-37,412
| -6% | -$364K | ﹤0.01% | 2239 |
|
|
2017
Q4 | $5.88M | Sell |
589,914
-65,067
| -10% | -$651K | ﹤0.01% | 2194 |
|
|
2017
Q3 | $6.6M | Buy |
654,981
+38,880
| +6% | +$393K | ﹤0.01% | 1954 |
|
|
2017
Q2 | $6.23M | Buy |
616,101
+63,605
| +12% | +$643K | ﹤0.01% | 1945 |
|
|
2017
Q1 | $5.53M | Buy |
552,496
+55,906
| +11% | +$560K | ﹤0.01% | 2010 |
|
|
2016
Q4 | $4.91M | Buy |
496,590
+71,879
| +17% | +$716K | ﹤0.01% | 2115 |
|
|
2016
Q3 | $4.3M | Buy |
+424,711
| New | +$4.29M | ﹤0.01% | 2161 |
|
UBS Group's JHB Position: Q4 2021 in Review
UBS Group sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q4 2021, closing a stake of 484,121 shares — an estimated $4.54M sold.
UBS Group first reported a position in JHB in Q3 2016 and held it in 21 quarters. The position peaked at $7.92M in Q2 2019. 0 funds tracked by Wall St. Rank hold JHB as of Q4 2021.
- UBS Group reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q4 2021 after selling out during the quarter.
- UBS Group sold 484,121 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2021, an estimated $4.54M.
- UBS Group first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q3 2016 and held it in 21 quarters.
- UBS Group's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $7.92M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2021.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.